
M
ammotomeŽ technology, a product of Ethicon Endo-Surgery (a Johnson &
Johnson company), represents an important breakthrough in the quest to diagnose
breast cancer at an early stage.
The
Mammotome Breast Biopsy System is a minimally invasive, image guided
procedure that helps physicians locate
breast abnormalities and obtain tissue samples for diagnosis.
In
stereotactic procedures, the patient lies face down on a special table with the
breast protruding through a hole in the table. The breast is lightly compressed
to immobilize it. This table is similar to the mammogram table, which allows
the physician to get a clear mammographic image of the area to be sampled. The
table is connected to a computer that processes digital images. Placement of
the sampling device is guided by a computerized system using x-rays.
Unlike
other biopsy methods, the Mammotome is capable of sampling a variety of breast
abnormalities with just one small incision.
The
Mammotome Breast Biopsy System
The
Mammotome Breast Biopsy System is different because it is minimally invasive
and requires only a 1/4" skin incision. This procedure can be performed in
less than one hour under a local anesthetic, minimizing discomfort to the
patient. The Mammotome is capable of sampling a variety of breast
abnormalities, such as microcalcifications, asymmetric densities, solid masses
or nodules. It can obtain multiple tissue samples with one insertion (other methods
require multiple insertions).
When
the biopsy is completed, the tissue samples are sent to a laboratory for
analysis and pathologic results. A procedure which requires no sutures, the
Mammotome is a valuable tool that helps physicians accurately diagnose breast
cancer in its earliest stages.
|